Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.
Journal: Current oncology reports
Published: May 05, 2026
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 08, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma.
Journal: Neuro-oncology advances
Published: February 29, 2024
Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients.
Journal: Current oncology reports
Published: October 06, 2023
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas.
Journal: Neuro-oncology advances
Published: August 09, 2023
Corrigendum to "Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review" [J. Clin. Neurosci. 89 (2021) 405-411].
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: August 04, 2021
Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: December 16, 2020
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
Journal: Cancer
Published: February 02, 2019
Last Updated: 09/26/2026